Literature DB >> 26401976

Pure fetal histology subtype was associated with better prognosis of children with hepatoblastoma: A Chinese population-based study.

Guo-liang Qiao1,2, Zhen Chen2, Chen Wang2, Juntao Ge2, Zhen Zhang2, Long Li2, Jun Ren1.   

Abstract

BACKGROUND AND AIM: The aim of this study is to identify the association between histologic types and the prognosis of hepatoblastoma (HB) in a large Asian cohort of a single institution and to explore the interaction of histologic types with other independently risk factors in the process of affecting prognosis of HB.
METHODS: We retrospectively reviewed 176 children with HB (82 female, 94 male) managed in our institution between May 1, 2001 and July 30, 2014. Prognostic factors were evaluated using Kaplan-Meier curves and Cox proportional hazards models.
RESULTS: For the entire cohort of 176 patients, the overall median survival was 80.4 months(95% CI: 71.6-89.2 months), and the 5-year event-free survival and overall survival rates were 54.6 and 66.7%. Descriptive survival statistics and Kaplan-Meier curves suggested that alpha fetoprotein levels, tumor metastases, multifocality, histologic types, and Pre-Treatment Extent of Disease staging System stage had prognostic significance in this relatively selected cohort. Moreover, after eliminating the impact of the interaction of different classification methods of histologic types, pure fetal histologic (PFH) was an independent prognostic factor of HB (hazard ratio [HR]: 2.752, P = 0.021). Further stratification analysis showed that the impaction of other identified risk factors on the influence of PFH on the prognosis of HB patients was different.
CONCLUSIONS: We have confirmed that the HB prognostic factors of HB and PFH was associated with better prognosis of children with HB based on an Asian population. PFH showed different significance in the process of affecting prognosis of HB with the interaction of other independent risk factors.
© 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  hepatoblastoma; histologic types; prognosis

Mesh:

Year:  2016        PMID: 26401976     DOI: 10.1111/jgh.13165

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.

Authors:  Laura L Stafman; Mary G Waldrop; Adele P Williams; Jamie M Aye; Jerry E Stewart; Elizabeth Mroczek-Musulman; Karina J Yoon; Kimberly Whelan; Elizabeth A Beierle
Journal:  J Pediatr Surg       Date:  2019-02-28       Impact factor: 2.545

2.  β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.

Authors:  Weiqi Zhang; Jennifer Meyfeldt; Huabo Wang; Sucheta Kulkarni; Jie Lu; Jordan A Mandel; Brady Marburger; Ying Liu; Joanna E Gorka; Sarangarajan Ranganathan; Edward V Prochownik
Journal:  J Biol Chem       Date:  2019-10-09       Impact factor: 5.157

3.  A single-center retrospective analysis of childhood hepatoblastoma in China.

Authors:  Wenya Yu; Xiang Liu; Jingquan Li; Zhifeng Xi; Jing Jin; Hongting Huang; Yang Ge; Qiang Xia
Journal:  Gland Surg       Date:  2020-10

4.  Molecular Mechanisms of Hepatoblastoma.

Authors:  Yi Zhang; Antonio Solinas; Stefano Cairo; Matthias Evert; Xin Chen; Diego F Calvisi
Journal:  Semin Liver Dis       Date:  2021-01-20       Impact factor: 6.115

5.  Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein.

Authors:  Rebecca MacDonell-Yilmaz; Kelly Anderson; Bradley DeNardo; Philippa Sprinz; William V Padula
Journal:  J Pediatr       Date:  2020-05-26       Impact factor: 4.406

6.  A Challenging Case of Hepatoblastoma Concomitant with Autosomal Recessive Polycystic Kidney Disease and Caroli Syndrome-Review of the Literature.

Authors:  Nevil Kadakia; Steven J Lobritto; Nadia Ovchinsky; Helen E Remotti; Darrell J Yamashiro; Jean C Emond; Mercedes Martinez
Journal:  Front Pediatr       Date:  2017-06-07       Impact factor: 3.418

7.  CHIC Risk Stratification System for Predicting the Survival of Children With Hepatoblastoma: Data From Children With Hepatoblastoma in China.

Authors:  Junting Huang; Yang Hu; Hong Jiang; Yanjie Xu; Suying Lu; Feifei Sun; Jia Zhu; Juan Wang; Xiaofei Sun; Juncheng Liu; Zijun Zhen; Yizhuo Zhang
Journal:  Front Oncol       Date:  2020-11-18       Impact factor: 6.244

Review 8.  Hepatoblastoma: current understanding, recent advances, and controversies.

Authors:  Piotr Czauderna; Hanna Garnier
Journal:  F1000Res       Date:  2018-01-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.